|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein]; diphenyleneiodonium inhibits the reaction [Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] |
CTD |
PMID:18474546 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
ISO |
diphenyleneiodonium results in decreased expression of ACTA2 protein diphenyleneiodonium promotes the reaction [mangostin results in decreased expression of ACTA2 protein]; mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein] |
CTD |
PMID:30502394 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of ADIPOQ protein]; diphenyleneiodonium inhibits the reaction [Lopinavir results in decreased expression of ADIPOQ protein]; diphenyleneiodonium inhibits the reaction [Nelfinavir results in decreased expression of ADIPOQ protein]; diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein] diphenyleneiodonium inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA]; diphenyleneiodonium inhibits the reaction [Palmitates results in decreased expression of ADIPOQ protein] |
CTD |
PMID:17471172 PMID:17668557 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [AGT protein modified form results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [AGT protein modified form results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [AGT protein results in increased expression of EDN1 mRNA] diphenyleneiodonium inhibits the reaction [AGT protein affects the localization of RHOA protein]; diphenyleneiodonium inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] |
CTD |
PMID:12606818 PMID:16569756 PMID:17391658 PMID:18250367 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Endosulfan results in increased phosphorylation of AKT1 protein] diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25199686 PMID:26514923 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [ALB protein results in increased abundance of Hydrogen Peroxide] |
CTD |
PMID:11961005 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Asbestos, Crocidolite affects the localization of APEX1 protein] |
CTD |
PMID:12023366 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:14687664 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Resveratrol affects the expression of BCL2 protein] |
CTD |
PMID:31151226 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bsg |
basigin (Ok blood group) |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL18 protein results in increased expression of BSG mRNA] |
CTD |
PMID:19561311 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein] |
CTD |
PMID:23940760 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [AGT protein modified form results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [Ethanol results in increased activity of CASP3 protein] diphenyleneiodonium inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [Docetaxel results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [ganoderic acid analog results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP3 protein] [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; diphenyleneiodonium inhibits the reaction [TGFB1 protein results in increased activity of CASP3 protein] |
CTD |
PMID:12606818 PMID:12754411 PMID:14732287 PMID:15331178 PMID:15799720 PMID:20026259 PMID:25947082 PMID:26282491 PMID:33577942 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
EXP ISO |
[diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] diphenyleneiodonium results in increased activity of CASP8 protein diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP8 protein] |
CTD |
PMID:15799720 PMID:33577942 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein]; diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]; diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein]; diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP9 protein] |
CTD |
PMID:26282491 PMID:33577942 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Patulin results in decreased activity of CAT protein] |
CTD |
PMID:33577942 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] |
CTD |
PMID:14576080 PMID:16600694 PMID:17668557 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA] |
CTD |
PMID:28321046 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd38 |
CD38 molecule |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [VAV2 protein affects the localization of CD38 protein]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased expression of and results in increased activity of CD38 protein] |
CTD |
PMID:23940720 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions |
ISO |
[CD40LG protein binds to and co-treated with CD40LG protein binds to and co-treated with CD40LG protein binds to and co-treated with diphenyleneiodonium] inhibits the reaction [Oxygen deficiency results in increased abundance of Reactive Oxygen Species] |
CTD |
PMID:22295117 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] |
CTD |
PMID:15978937 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CEBPB protein] |
CTD |
PMID:25199686 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA]; diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] |
CTD |
PMID:23816505 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CREB1 protein] |
CTD |
PMID:25199686 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Ctf1 |
cardiotrophin 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [cobaltous chloride results in increased expression of CTF1 protein]; diphenyleneiodonium inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein] |
CTD |
PMID:16507596 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Methanol results in increased expression of CYBA mRNA]; diphenyleneiodonium inhibits the reaction [Methanol results in increased expression of CYBA protein] |
CTD |
PMID:25726414 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYBB mRNA]; diphenyleneiodonium inhibits the reaction [Aflatoxin B1 results in increased expression of CYBB protein]; diphenyleneiodonium inhibits the reaction [S100B protein results in increased expression of CYBB mRNA] diphenyleneiodonium inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA]; diphenyleneiodonium inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB protein] diphenyleneiodonium inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CYBB protein]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein] |
CTD |
PMID:17327432 PMID:23272707 PMID:29183754 PMID:30797899 PMID:34396909 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [Nicotine results in increased expression of CYP1A1 mRNA]; diphenyleneiodonium inhibits the reaction [sodium arsenite promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]] diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein] |
CTD |
PMID:26535918 PMID:26880746 PMID:34171359 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
EXP |
diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein] diphenyleneiodonium results in decreased activity of CYP1A2 protein |
CTD |
PMID:26880746 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
EXP |
diphenyleneiodonium inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein] diphenyleneiodonium results in decreased activity of CYP2E1 protein |
CTD |
PMID:26880746 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
EXP |
diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A2 protein] diphenyleneiodonium results in decreased activity of CYP3A4 protein |
CTD |
PMID:26880746 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A23-3A1 protein]; diphenyleneiodonium inhibits the reaction [Dexamethasone results in increased activity of CYP3A23-3A1 protein]; diphenyleneiodonium inhibits the reaction [Isoniazid results in increased activity of CYP3A23-3A1 protein]; diphenyleneiodonium inhibits the reaction [Pregnenolone Carbonitrile results in increased activity of CYP3A23-3A1 protein] |
CTD |
PMID:26880746 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Des |
desmin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES protein] |
CTD |
PMID:20036696 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Paraquat affects the localization of DIABLO protein] |
CTD |
PMID:25947082 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased activity of DIO2 protein] |
CTD |
PMID:17615150 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA] |
CTD |
PMID:28321046 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [AGT protein results in increased expression of EDN1 mRNA] diphenyleneiodonium inhibits the reaction [EDN1 protein results in increased oxidation of PTPN11 protein]; diphenyleneiodonium inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; diphenyleneiodonium inhibits the reaction [Streptozocin promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]] |
CTD |
PMID:16391241 PMID:17391658 PMID:20691780 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
EXP ISO |
diphenyleneiodonium inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of EGFR protein] |
CTD |
PMID:16391241 PMID:26514923 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]] |
CTD |
PMID:19281832 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Air Pollutants results in increased expression of F3 mRNA]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased expression of F3 mRNA] |
CTD |
PMID:24752501 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
EXP |
[diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased expression of FASL protein] |
CTD |
PMID:15799720 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP ISO |
diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; diphenyleneiodonium inhibits the reaction [Pyruvaldehyde results in increased expression of FN1 mRNA] diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of FN1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of FN1 mRNA] |
CTD |
PMID:15086456 PMID:16632126 PMID:17635749 PMID:31838053 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of FOS protein] |
CTD |
PMID:25199686 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [VEGFA protein results in increased phosphorylation of FOXO1 protein] |
CTD |
PMID:15308628 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions |
EXP |
diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI2 protein]; diphenyleneiodonium inhibits the reaction [Streptozocin results in decreased expression of GNAI2 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
EXP |
diphenyleneiodonium affects the reaction [Glucose results in decreased expression of GNAI3 protein]; diphenyleneiodonium inhibits the reaction [Streptozocin results in decreased expression of GNAI3 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Patulin results in decreased activity of GSR protein] |
CTD |
PMID:33577942 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gypa |
glycophorin A |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] |
CTD |
PMID:20523355 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Aflatoxin B1 results in increased expression of H2AX protein]; diphenyleneiodonium inhibits the reaction [niraparib results in increased expression of H2AX protein] |
CTD |
PMID:34396909 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression decreases expression |
ISO EXP |
diphenyleneiodonium inhibits the reaction [[[Arsenic results in increased abundance of Reactive Oxygen Species] which results in increased expression of HIF1A protein] which results in increased expression of VEGFA mRNA]; diphenyleneiodonium inhibits the reaction [[Arsenic results in increased abundance of Reactive Oxygen Species] which results in increased expression of HIF1A protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased expression of HIF1A protein] diphenyleneiodonium results in increased expression of HIF1A protein diphenyleneiodonium results in decreased expression of HIF1A protein |
CTD |
PMID:12595275 PMID:21687637 PMID:21984483 PMID:23144690 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
decreases secretion multiple interactions |
ISO |
diphenyleneiodonium results in decreased secretion of HMGB1 protein diphenyleneiodonium promotes the reaction [mangostin results in decreased secretion of HMGB1 protein]; mangostin promotes the reaction [diphenyleneiodonium results in decreased secretion of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased activity of HMOX1 protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein]; diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate results in increased expression of HMOX1 protein] diphenyleneiodonium inhibits the reaction [arsenic trioxide results in increased expression of HMOX1 protein]; diphenyleneiodonium inhibits the reaction [monomethylarsonous acid results in increased expression of HMOX1 protein] |
CTD |
PMID:18336854 PMID:20934533 PMID:26945724 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Paraquat affects the localization of HTR2A protein] |
CTD |
PMID:25947082 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of ICAM1 protein] |
CTD |
PMID:19632255 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
diphenyleneiodonium results in decreased susceptibility to [IFNG protein co-treated with Lipopolysaccharides] |
CTD |
PMID:16307444 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein] |
CTD |
PMID:20733350 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19940258 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL18 protein results in increased abundance of Reactive Oxygen Species]; diphenyleneiodonium inhibits the reaction [IL18 protein results in increased expression of BSG mRNA] diphenyleneiodonium inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL18 protein]; diphenyleneiodonium inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL18 protein] |
CTD |
PMID:19561311 PMID:27311643 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases response to substance |
ISO |
diphenyleneiodonium inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL1B protein]; diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; diphenyleneiodonium inhibits the reaction [Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; diphenyleneiodonium inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL1B protein] diphenyleneiodonium results in decreased susceptibility to IL1B protein diphenyleneiodonium inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; diphenyleneiodonium inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; diphenyleneiodonium inhibits the reaction [IL1B protein affects the localization of NCF1 protein]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased abundance of Reactive Oxygen Species]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased secretion of IL1B protein]; diphenyleneiodonium inhibits the reaction [Uric Acid results in increased secretion of IL1B protein] |
CTD |
PMID:18403674 PMID:19005069 PMID:19281832 PMID:21211511 PMID:23940760 PMID:24685903 PMID:27311643 PMID:27393034 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of IL6 protein]; diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of IL6 protein]; diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of IL6 protein]; diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of IL6 protein] |
CTD |
PMID:11950692 PMID:17668557 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [INS protein results in increased expression of TRPC6 protein] |
CTD |
PMID:22031853 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Itga2b |
integrin subunit alpha 2b |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGA2B protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of ITGAM mRNA] |
CTD |
PMID:16357311 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb3 |
integrin subunit beta 3 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB3 protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased phosphorylation of JUN protein]; diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of JUN protein] |
CTD |
PMID:14687664 PMID:25199686 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of LEP protein]; diphenyleneiodonium inhibits the reaction [Lopinavir results in decreased expression of LEP protein]; diphenyleneiodonium inhibits the reaction [Nelfinavir results in decreased expression of LEP protein]; diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of LEP protein] |
CTD |
PMID:17668557 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein] |
CTD |
PMID:12388057 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [[Arsenic results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased activity of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] diphenyleneiodonium inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11880281 PMID:15978937 PMID:16571865 PMID:16632126 PMID:17384286 PMID:19371610 PMID:19429262 PMID:19804834 PMID:21391979 PMID:21687637 PMID:21984483 PMID:22142850 PMID:23774252 PMID:25199686 PMID:26514923 PMID:30766661 PMID:31838053 PMID:34890707 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:19767766 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [[Arsenic results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased activity of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] diphenyleneiodonium inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11880281 PMID:15978937 PMID:16571865 PMID:16632126 PMID:17384286 PMID:19371610 PMID:19429262 PMID:19804834 PMID:21391979 PMID:21687637 PMID:21984483 PMID:22142850 PMID:23774252 PMID:25199686 PMID:26514923 PMID:30766661 PMID:31838053 PMID:34890707 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK8 protein]; diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]; diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:21391979 PMID:26514923 PMID:30766661 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; diphenyleneiodonium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]; diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:21391979 PMID:26514923 PMID:30766661 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased expression of MMP1 mRNA]; diphenyleneiodonium inhibits the reaction [Vehicle Emissions results in increased expression of MMP1 mRNA] |
CTD |
PMID:17449795 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
decreases expression multiple interactions |
ISO |
diphenyleneiodonium results in decreased expression of MMP12 mRNA diphenyleneiodonium inhibits the reaction [Ethanol results in increased expression of MMP12 mRNA] |
CTD |
PMID:23978445 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP13 protein] |
CTD |
PMID:21211511 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Doxorubicin results in increased expression of MMP2 mRNA] |
CTD |
PMID:16213474 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]; diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased expression of MMP9 mRNA]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] diphenyleneiodonium inhibits the reaction [RELA protein binds to MMP9 promoter]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; diphenyleneiodonium promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA] |
CTD |
PMID:15557194 PMID:16213474 PMID:19804834 PMID:23774252 PMID:26514923 PMID:30766661 More...
|
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [manganese chloride promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of MPO protein]] |
CTD |
PMID:22906169 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Resveratrol affects the expression of MYC protein] |
CTD |
PMID:31151226 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19940258 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IL1B protein affects the localization of NCF1 protein] |
CTD |
PMID:19281832 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which affects the localization of NFATC1 protein] |
CTD |
PMID:22564430 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfatc3 |
nuclear factor of activated T-cells 3 |
multiple interactions |
EXP |
[diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin affects the localization of NFATC3 protein] |
CTD |
PMID:15799720 |
|
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate affects the localization of NFE2L2 protein] |
CTD |
PMID:26945724 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases activity |
ISO |
diphenyleneiodonium inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] diphenyleneiodonium results in decreased activity of NFKB1 protein diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:11950692 PMID:12477282 PMID:18922898 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases activity affects activity |
ISO |
diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] diphenyleneiodonium results in decreased activity of NOS2 protein diphenyleneiodonium affects the activity of NOS2 protein |
CTD |
PMID:19005069 PMID:26880746 PMID:31306686 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein] |
CTD |
PMID:26906511 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox1 |
NADPH oxidase 1 |
decreases activity multiple interactions |
ISO |
diphenyleneiodonium results in decreased activity of NOX1 protein [diphenyleneiodonium results in decreased activity of NOX1 protein] inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased abundance of Reactive Oxygen Species]; [diphenyleneiodonium results in decreased activity of NOX1 protein] which results in decreased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; diphenyleneiodonium inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOX1 mRNA] diphenyleneiodonium inhibits the reaction [NOX1 protein results in increased abundance of Superoxides] |
CTD |
PMID:16393473 PMID:22307971 PMID:24912985 PMID:30797899 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein] |
CTD |
PMID:26906511 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein] |
CTD |
PMID:20036696 |
|
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein] |
CTD |
PMID:20036696 |
|
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
|
|
G |
Park7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of PARK7 protein] |
CTD |
PMID:11811539 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein] diphenyleneiodonium inhibits the reaction [Paraquat results in increased cleavage of PARP1 protein] |
CTD |
PMID:14687664 PMID:25947082 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions decreases activity |
ISO EXP |
diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased abundance of Hydrogen Peroxide]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased metabolism of NADP]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased metabolism of Oxygen]; diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased activity of POR protein] diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydroxyl Radical]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP] diphenyleneiodonium inhibits the reaction [POR protein affects the metabolism of Nitrofurantoin] diphenyleneiodonium results in decreased activity of POR protein |
CTD |
PMID:18206659 PMID:20934533 PMID:21215309 PMID:31356851 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [AGT protein results in increased phosphorylation of PPP1R12A protein] |
CTD |
PMID:16569756 |
|
NCBI chr 7:43,482,808...43,593,689
Ensembl chr 7:43,482,803...43,593,425
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO EXP |
diphenyleneiodonium inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) affects the localization of PRKCD protein]; diphenyleneiodonium inhibits the reaction [Ursodeoxycholic Acid results in increased localization of PRKCD protein] diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of PRKCD protein] |
CTD |
PMID:12821678 PMID:21362627 PMID:21420390 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) affects the localization of PRKCE protein] |
CTD |
PMID:21420390 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] |
CTD |
PMID:17320767 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] diphenyleneiodonium inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 protein]; diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of PTGS2 mRNA]; diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of PTGS2 protein]; diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] |
CTD |
PMID:14687664 PMID:16024921 PMID:19804834 PMID:22288910 PMID:25199686 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein] |
CTD |
PMID:23774252 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [EDN1 protein results in increased oxidation of PTPN11 protein] |
CTD |
PMID:16391241 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Fungal Polysaccharides results in increased activity of RAC1 protein] |
CTD |
PMID:24447977 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
diphenyleneiodonium inhibits the reaction [RELA protein binds to MMP9 promoter]; diphenyleneiodonium inhibits the reaction [TNF protein affects the localization of RELA protein] diphenyleneiodonium inhibits the reaction [[Carmustine co-treated with Oligodeoxyribonucleotides analog] results in increased activity of [NFKB1 protein binds to RELA protein]]; diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of RELA protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] diphenyleneiodonium inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; diphenyleneiodonium inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]]; diphenyleneiodonium inhibits the reaction [VEGFA protein affects the localization of RELA protein] |
CTD |
PMID:11950692 PMID:12477282 PMID:15308628 PMID:19281832 PMID:19608869 PMID:23774252 PMID:25199686 PMID:27393034 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [AGT protein affects the localization of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] |
CTD |
PMID:16569756 PMID:18250367 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:21984483 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
S100b |
S100 calcium binding protein B |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [S100B protein results in increased expression of CYBB mRNA] |
CTD |
PMID:17327432 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of SCARB1 protein] |
CTD |
PMID:22442701 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [erastin results in increased expression of SESN2 protein] |
CTD |
PMID:31323261 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Glucose results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:31838053 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
EXP |
diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of SMAD4 protein] |
CTD |
PMID:31838053 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
[N-((3-(aminomethyl)phenyl)methyl)ethanimidamide co-treated with diphenyleneiodonium] inhibits the reaction [SNCA protein mutant form results in increased susceptibility to Lipopolysaccharides] |
CTD |
PMID:21245015 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] |
CTD |
PMID:10601319 PMID:21705328 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of STAT3 protein]; diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of STAT3 protein]; diphenyleneiodonium inhibits the reaction [THPO protein results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:19429262 PMID:20523355 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of STAT5A protein]; diphenyleneiodonium inhibits the reaction [THPO protein results in increased phosphorylation of STAT5A protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Arsenic Trioxide results in decreased activity of TERT protein]; diphenyleneiodonium inhibits the reaction [monomethylarsonous acid results in decreased activity of TERT protein] |
CTD |
PMID:18336854 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; diphenyleneiodonium inhibits the reaction [Pyruvaldehyde results in increased expression of TGFB1 mRNA]; diphenyleneiodonium inhibits the reaction [Pyruvaldehyde results in increased expression of TGFB1 protein]; diphenyleneiodonium inhibits the reaction [TGFB1 protein results in decreased abundance of Glutathione]; diphenyleneiodonium inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species]; diphenyleneiodonium inhibits the reaction [TGFB1 protein results in increased activity of CASP3 protein] diphenyleneiodonium inhibits the reaction [4-cresol sulfate results in increased expression of and results in increased secretion of TGFB1 protein] |
CTD |
PMID:14732287 PMID:17635749 PMID:23325087 PMID:31838053 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thpo |
thrombopoietin |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [THPO protein results in increased phosphorylation of STAT3 protein]; diphenyleneiodonium inhibits the reaction [THPO protein results in increased phosphorylation of STAT5A protein] |
CTD |
PMID:20523355 |
|
Ensembl chr11:80,182,820...80,188,167
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases response to substance |
ISO EXP |
diphenyleneiodonium inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of FN1 mRNA]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased secretion of IL1B protein] diphenyleneiodonium results in decreased susceptibility to TNF protein diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] diphenyleneiodonium inhibits the reaction [Palmitates results in increased expression of TNF mRNA]; diphenyleneiodonium inhibits the reaction [Palmitates results in increased expression of TNF protein]; diphenyleneiodonium inhibits the reaction [Particulate Matter results in increased expression of TNF protein]; diphenyleneiodonium inhibits the reaction [TNF protein affects the localization of RELA protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [Vehicle Emissions results in increased expression of TNF protein] |
CTD |
PMID:12388057 PMID:14576080 PMID:16632126 PMID:17471172 PMID:18474546 PMID:19608869 PMID:21211511 PMID:23774252 PMID:23940760 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions decreases expression |
ISO |
diphenyleneiodonium inhibits the reaction [INS protein results in increased expression of TRPC6 protein] diphenyleneiodonium results in decreased expression of TRPC6 protein |
CTD |
PMID:22031853 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
ISO |
diphenyleneiodonium promotes the reaction [NCX 4040 results in increased oxidation of TXN1 protein] |
CTD |
PMID:18922898 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [Paraquat results in increased activity of TXNRD1 protein]; diphenyleneiodonium inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid] |
CTD |
PMID:17229725 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
ISO |
[diphenyleneiodonium co-treated with Benzo(a)pyrene] results in increased activity of TYR protein; diphenyleneiodonium promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of TYR protein] |
CTD |
PMID:34856342 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Vav2 |
vav guanine nucleotide exchange factor 2 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [VAV2 protein affects the localization of CD38 protein]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased expression of and results in increased activity of CD38 protein] |
CTD |
PMID:23940720 |
|
NCBI chr 3:10,584,688...10,754,128
Ensembl chr 3:10,584,688...10,754,052
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of VCAM1 protein]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; diphenyleneiodonium inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein] |
CTD |
PMID:19281832 PMID:19632255 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [[[Arsenic results in increased abundance of Reactive Oxygen Species] which results in increased expression of HIF1A protein] which results in increased expression of VEGFA mRNA]; diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; diphenyleneiodonium inhibits the reaction [VEGFA protein affects the localization of RELA protein]; diphenyleneiodonium inhibits the reaction [VEGFA protein results in increased phosphorylation of FOXO1 protein] diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein] |
CTD |
PMID:15308628 PMID:20116427 PMID:21687637 PMID:23144690 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Zfp143 |
zinc finger protein 143 |
multiple interactions |
ISO |
diphenyleneiodonium inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein] |
CTD |
PMID:20733350 |
|
NCBI chr 1:164,109,041...164,144,902
Ensembl chr 1:164,109,116...164,144,902
|
|